TY - JOUR
T1 - Rational Design of Nanocarriers for Intracellular Protein Delivery
AU - Qin, Xiaofei
AU - Yu, Changmin
AU - Wei, Jing
AU - Li, Lin
AU - Zhang, Chengwu
AU - Wu, Qiong
AU - Liu, Jinhua
AU - Yao, Shao Q.
AU - Huang, Wei
N1 - Publisher Copyright:
© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
PY - 2019/11/1
Y1 - 2019/11/1
N2 - Protein/antibody therapeutics have exhibited the advantages of high specificity and activity even at an extremely low concentration compared to small molecule drugs. However, they are accompanied by unfavorable physicochemical properties such as fragile tertiary structure, large molecular size, and poor penetration of the membrane, and thus the clinical use of protein drugs is hindered by inefficient delivery of proteins into the host cells. To overcome the challenges associated with protein therapeutics and enhance their biopharmaceutical applications, various protein-loaded nanocarriers with desired functions, such as lipid nanocapsules, polymeric nanoparticles, inorganic nanoparticles, and peptides, are developed. In this review, the different strategies for intracellular delivery of proteins are comprehensively summarized. Their designed routes, mechanisms of action, and potential therapeutics in live cells or in vivo are discussed in detail. Furthermore, the perspective on the new generation of delivery systems toward the emerging area of protein-based therapeutics is presented as well.
AB - Protein/antibody therapeutics have exhibited the advantages of high specificity and activity even at an extremely low concentration compared to small molecule drugs. However, they are accompanied by unfavorable physicochemical properties such as fragile tertiary structure, large molecular size, and poor penetration of the membrane, and thus the clinical use of protein drugs is hindered by inefficient delivery of proteins into the host cells. To overcome the challenges associated with protein therapeutics and enhance their biopharmaceutical applications, various protein-loaded nanocarriers with desired functions, such as lipid nanocapsules, polymeric nanoparticles, inorganic nanoparticles, and peptides, are developed. In this review, the different strategies for intracellular delivery of proteins are comprehensively summarized. Their designed routes, mechanisms of action, and potential therapeutics in live cells or in vivo are discussed in detail. Furthermore, the perspective on the new generation of delivery systems toward the emerging area of protein-based therapeutics is presented as well.
KW - inorganic nanoparticles
KW - lipids
KW - polymeric nanoparticles
KW - protein delivery
UR - http://www.scopus.com/inward/record.url?scp=85071917341&partnerID=8YFLogxK
U2 - 10.1002/adma.201902791
DO - 10.1002/adma.201902791
M3 - 文献综述
C2 - 31496027
AN - SCOPUS:85071917341
SN - 0935-9648
VL - 31
JO - Advanced Materials
JF - Advanced Materials
IS - 46
M1 - 1902791
ER -